Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis

Annals of Internal Medicine

Volumn 157, Issue 4, 2012, Pages 299-

  Pincus, Theodore ^a   Castrejon, Isabel ^a   Yazici, Yusuf ^a  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; PREDNISONE; ANTIRHEUMATIC AGENT; GLUCOCORTICOID;

ADRENAL SUPPRESSION; ATHEROSCLEROSIS; CORTICOSTEROID THERAPY; HUMAN; LETTER; LONG TERM CARE; LOW DRUG DOSE; MORTALITY; OSTEOPOROSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; THERAPY EFFECT; FEMALE; MALE; NOTE; RADIOGRAPHY;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; METHOTREXATE; PREDNISONE;

EID: 84865628169     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-157-4-201208210-00018     Document Type: Letter

References (5)

1. Bakker MF, Jacobs JW, Welsing PM, Verstappen SM, Tekstra J, Ton E, et al; Utrecht Rheumatoid Arthritis Cohort Study Group. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial. Ann Intern Med. 2012;156:329-39.
2. Pincus T, Bijlsma JW, Braun J, Buttgereit F, Cutolo M. Low-dose glucocorticoids in rheumatic diseases: introduction. Clin Exp Rheumatol. 2011;29:S2-4.
3. Wassenberg S, Rau R, Steinfeld P, Zeidler H. Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum. 2005;52:3371-80.
4. Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med. 2004;141:764-70.
5. Pincus T, Sokka T, Stein CM. Are long-term very low doses of prednisone for patients with rheumatoid arthritis as helpful as high doses are harmful? [Editorial]. Ann Intern Med. 2002;136:76-8.